Copyright
©The Author(s) 2015.
World J Stem Cells. May 26, 2015; 7(4): 776-788
Published online May 26, 2015. doi: 10.4252/wjsc.v7.i4.776
Published online May 26, 2015. doi: 10.4252/wjsc.v7.i4.776
Figure 1 Morphology (A) and characterization of fetal kidney stem cells (B and C).
A: Representative photomicrograph (Scale bars indicate 100 μm) showing spindle-shaped and polygonal morphology of fetal kidney stem cells (fKSC); B: Phenotypic characterization of fKSC by flow cytometry showing expression of CD29, CD44, CD73, CD90, CD105, CD45, and MHC class II (green or red lines, detected with FITC - or phycoerythrin-conjugated antibodies, respectively) with isotype controls (black lines); C: Representative immunoflourescent photomicrographs (Scale bars indicate 20 μm) showing expression of renal progenitor markers viz. Wt1, Pax2 and Six2 on fKSC.
- Citation: Gupta AK, Jadhav SH, Tripathy NK, Nityanand S. Fetal kidney stem cells ameliorate cisplatin induced acute renal failure and promote renal angiogenesis. World J Stem Cells 2015; 7(4): 776-788
- URL: https://www.wjgnet.com/1948-0210/full/v7/i4/776.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v7.i4.776